MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
-3.69%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(+7.3%)
Cap. Flow
+$23.5M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
59.56%
Holding
77
New
11
Increased
21
Reduced
21
Closed
5
Top Buys
| 1 |
Alcoa
AA
|
$15.8M |
| 2 |
AngloGold Ashanti
AU
|
$9.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.17M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$6.02M |
| 5 |
Pan American Silver
PAAS
|
$4.1M |
Top Sells
| 1 |
UBS Group
UBS
|
$5.91M |
| 2 |
Alibaba
BABA
|
$5.42M |
| 3 |
Hecla Mining
HL
|
$4.83M |
| 4 |
CELL
PhenomeX Inc. Common Stock
CELL
|
$3.38M |
| 5 |
LendingTree
TREE
|
$3.36M |
Sector Composition
| 1 | Materials | 27.25% |
| 2 | Healthcare | 26.81% |
| 3 | Technology | 11.14% |
| 4 | Financials | 5.35% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sibanye-Stillwater
SBSW
$5.86B
| $2.22M | 0.66% |
359,358
-150,000
| -29% | -$926K |
|
|
27
Hecla Mining
HL
$5.98B
| $2.21M | 0.66% |
565,000
-1,235,000
| -69% | -$4.83M |
|
28
JD.com
JD
$44.8B
| $2.2M | 0.65% |
75,426
| – | – |
|
29
Forum Energy Technologies
FET
$312M
| $2.17M | 0.64% |
90,145
+19,020
| +27% | +$457K |
|
|
TSP
30
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.98M | 0.59% |
1,268,972
+316,202
| +33% | +$493K |
|
31
Sprott Physical Silver Trust
PSLV
$7.61B
| $1.74M | 0.52% |
230,000
| – | – |
|
|
SOL
32
Emeren Group
SOL
$94.9M
| $1.71M | 0.51% |
556,327
+280,000
| +101% | +$862K |
|
|
NBIS
33
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $1.56M | 0.46% |
105,000
| – | – |
|
34
Esperion Therapeutics
ESPR
$468M
| $1.15M | 0.34% |
1,171,779
+476,477
| +69% | +$467K |
|
35
Peloton Interactive
PTON
$3.01B
| $1.14M | 0.34% |
225,000
+210,000
| +1,400% | +$1.06M |
|
36
Baidu
BIDU
$33.1B
| $1.07M | 0.32% |
8,000
-8,500
| -52% | -$1.14M |
|
37
Alico
ALCO
$259M
| $995K | 0.29% |
39,845
| – | – |
|
38
Kodiak Sciences
KOD
$455M
| $889K | 0.26% |
493,726
+278,605
| +130% | +$501K |
|
39
Chewy
CHWY
$16.3B
| $867K | 0.26% |
+47,500
| New | +$867K |
|
40
Cue Biopharma
CUE
$60.9M
| $827K | 0.25% |
359,739
-10,668
| -3% | -$24.5K |
|
|
NGD
41
New Gold Inc
NGD
$4.85B
| $785K | 0.23% |
862,084
-926,753
| -52% | -$843K |
|
|
FTCH
42
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $777K | 0.23% |
371,656
-78,344
| -17% | -$164K |
|
|
MREO
43
Mereo BioPharma
MREO
$281M
| $768K | 0.23% |
595,729
-110,000
| -16% | -$142K |
|
44
Valaris
VAL
$3.5B
| $750K | 0.22% |
10,000
-40,000
| -80% | -$3M |
|
45
NOV
NOV
$4.86B
| $732K | 0.22% |
35,000
-25,000
| -42% | -$523K |
|
46
Ericsson
ERIC
$25.8B
| $729K | 0.22% |
150,000
+50,000
| +50% | +$243K |
|
47
Heron Therapeutics
HRTX
$202M
| $718K | 0.21% |
696,908
+291,908
| +72% | +$301K |
|
48
Vanda Pharmaceuticals
VNDA
$278M
| $583K | 0.17% |
+135,000
| New | +$583K |
|
49
First Majestic Silver
AG
$4.69B
| $513K | 0.15% |
+100,000
| New | +$513K |
|
50
ProQR Therapeutics
PRQR
$241M
| $491K | 0.15% |
377,517
+140,000
| +59% | +$182K |
|